6,052 filings
Page 69 of 100
F-3
rifm038mso65
3 Apr 17
Shelf registration (foreign)
12:00am
6-K
pa121tvcb3t tds1
3 Apr 17
Total Voting Rights
12:00am
6-K
s75cmy 7itimo
31 Mar 17
Phase 3 Study Start of Mepolizumab In Severe Hes
12:00am
4/A
obptfma3
30 Mar 17
Change in insider ownership (amended)
12:00am
6-K
4ioog5n9
30 Mar 17
Notice of Agm
12:00am
4
07hbe2rg0
29 Mar 17
Change in insider ownership
12:00am
SC 13D/A
bkw3bggo8c1y1pusc
29 Mar 17
HTG Molecular Diagnostics, Inc
12:00am
6-K
v1xo h7kjz0ky3rwlm
23 Mar 17
Director/pdmr Shareholding
12:00am
6-K
c4x4vk0i3qik
21 Mar 17
Director/pdmr Shareholding
12:00am
6-K
e8gn2wg2qfgwfs4dx tp
20 Mar 17
GSK 2016 Form 20F
12:00am
IRAN
fe6c3 pdl0w9xtg8
17 Mar 17
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
12:00am
6-K
8ui5l
16 Mar 17
Director/pdmr Shareholding
12:00am
6-K
o8e4r
15 Mar 17
Director/pdmr Shareholding
12:00am
6-K
8by5z
14 Mar 17
Publication of 2016 Annual Financial Report
12:00am
6-K
3ffndl0p6cqkb
10 Mar 17
Director/pdmr Shareholding
12:00am
6-K
o6jfosr2coys
8 Mar 17
Director/pdmr Shareholding
12:00am
6-K
h9ozc1z h4xm
6 Mar 17
GSKS Musca Study Results on Nucala (Mepolizumab)
12:00am
6-K
q9c92sg 220e
6 Mar 17
Director/pdmr Shareholding
12:00am
6-K
8hli7puf3ep6bmve0my
1 Mar 17
Total Voting Rights
12:00am